We are a cell engineering company focused on commercialising the application of gene editing and gene modulation to accelerate scientific innovation and biopharmaceutical drug development.
Built upon decades of experience in the engineering of cell lines, we have created a unique and high value portfolio of tools and services, which enable almost any gene to be altered or its function modulated, in human and other mammalian cell lines.
Our offerings support and enable critical elements of the drug development and therapeutic value chain, particularly in the area of precision medicine.
Our latest results at a glance
Increase by 7.8%
Group gross margin
How we create value
We are focused on commercialising the application of gene editing and gene modulation technologies to accelerate scientific innovation and biopharmaceutical drug development